These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18809794)

  • 1. Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction.
    Le Tourneau T; Susen S; Caron C; Millaire A; Maréchaux S; Polge AS; Vincentelli A; Mouquet F; Ennezat PV; Lamblin N; de Groote P; Van Belle E; Deklunder G; Goudemand J; Bauters C; Jude B
    Circulation; 2008 Oct; 118(15):1550-7. PubMed ID: 18809794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter by Dimitrow and Undas regarding article, "Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction".
    Dimitrow PP; Undas A
    Circulation; 2009 Jun; 119(23):e590; author reply e591. PubMed ID: 19528342
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of Von Willebrand Factor Activity Indexes to Predict Therapeutic Response in Hypertrophic Cardiomyopathy.
    Blackshear JL; Kusumoto H; Safford RE; Wysokinska E; Thomas CS; Waldo OA; Stark ME; Shapiro BP; Ung S; Moussa I; Agnew RC; Landolfo K; Chen D
    Am J Cardiol; 2016 Feb; 117(3):436-42. PubMed ID: 26705879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
    Maron MS; Olivotto I; Zenovich AG; Link MS; Pandian NG; Kuvin JT; Nistri S; Cecchi F; Udelson JE; Maron BJ
    Circulation; 2006 Nov; 114(21):2232-9. PubMed ID: 17088454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting functional impairment in hypertrophic cardiomyopathy by dynamic assessment of diastolic reserve and outflow obstruction: A combined cardiopulmonary-echocardiographic study.
    Re F; Zachara E; Avella A; Baratta P; di Mauro M; Uguccioni M; Olivotto I
    Int J Cardiol; 2017 Jan; 227():743-750. PubMed ID: 27839814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of dobutamine stress echocardiography and exercise echocardiography in evaluating left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy].
    Shao CL; Duan FJ; Qiao SB; You SJ; Hu FH; Yuan JS; Yang WX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):214-8. PubMed ID: 22801266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
    Sorensen LL; Liang HY; Pinheiro A; Hilser A; Dimaano V; Olsen NT; Hansen TF; Sogaard P; Nowbar A; Pisanello C; Pozios I; Phillip S; Zhou X; Abraham R; Abraham TP
    Am Heart J; 2017 Feb; 184():47-54. PubMed ID: 27892886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
    Shah JS; Esteban MT; Thaman R; Sharma R; Mist B; Pantazis A; Ward D; Kohli SK; Page SP; Demetrescu C; Sevdalis E; Keren A; Pellerin D; McKenna WJ; Elliott PM
    Heart; 2008 Oct; 94(10):1288-94. PubMed ID: 18032461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of resting and exercise echocardiographic parameters as indicators of outcomes in hypertrophic cardiomyopathy.
    Reant P; Reynaud A; Pillois X; Dijos M; Arsac F; Touche C; Landelle M; Rooryck C; Roudaut R; Lafitte S
    J Am Soc Echocardiogr; 2015 Feb; 28(2):194-203. PubMed ID: 25459499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
    Desai MY; Bhonsale A; Patel P; Naji P; Smedira NG; Thamilarasan M; Lytle BW; Lever HM
    JACC Cardiovasc Imaging; 2014 Jan; 7(1):26-36. PubMed ID: 24290569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of left ventricular outflow gradient: hypertrophic cardiomyopathy versus aortic valvular stenosis.
    Geske JB; Cullen MW; Sorajja P; Ommen SR; Nishimura RA
    JACC Cardiovasc Interv; 2012 Jun; 5(6):675-81. PubMed ID: 22721664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rest and latent obstruction in hypertrophic cardiomyopathy: impact on exercise tolerance.
    Re F; Zachara E; Avella A; Baratta P; Di Mauro M; Penco M; Musumeci F; Tondo C
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):372-9. PubMed ID: 22728835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy.
    Cambronero F; Vilchez JA; García-Honrubia A; Ruiz-Espejo F; Moreno V; Hernández-Romero D; Bonacasa B; González-Conejero R; de la Morena G; Martínez P; Climent V; Valdés M; Marín F
    Thromb Res; 2010 Jul; 126(1):e46-50. PubMed ID: 20156645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy.
    Nistri S; Olivotto I; Maron MS; Grifoni C; Baldini K; Baldi M; Sgalambro A; Cecchi F; Maron BJ
    Am J Cardiol; 2010 Nov; 106(9):1301-6. PubMed ID: 21029828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exercise echocardiography in the evaluation of obstructive types of hypertrophic cardiomyopathy].
    Shao CL; Duan FJ; Qiao SB; You SJ; Hu FH; Yuan JS
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):484-8. PubMed ID: 24059995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Left intraventricular gradients measured by Doppler echocardiography at rest, during exercise and during isoproterenol test in hypertrophic cardiomyopathy].
    Decoulx E; Goullard L; Millaire A; Lecroart JL; de Groote P; Houdas Y; Ducloux G
    Arch Mal Coeur Vaiss; 1992 Jun; 85(6):839-45. PubMed ID: 1417402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy.
    Lu DY; Hailesealassie B; Ventoulis I; Liu H; Liang HY; Nowbar A; Pozios I; Canepa M; Cresswell K; Luo HC; Abraham MR; Abraham TP
    Int J Cardiol; 2017 Sep; 243():290-295. PubMed ID: 28747034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
    J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between outflow obstruction and left ventricular functional impairment in hypertrophic cardiomyopathy: a Doppler echocardiographic study.
    Araujo AQ; Arteaga E; Ianni BM; Fernandes F; Ramires FJ; Buck PC; Salemi VM; Nastari L; Mady C
    Echocardiography; 2006 Oct; 23(9):734-40. PubMed ID: 16999691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.